Roberto Saviane
Direktor/Vorstandsmitglied bei Pitagora SpA
Profil
Roberto Saviane is currently a Director at Pitagora SpA.
Previously, he was the Chairman at DeA Capital Alternative Funds SGR SpA from 2011 to 2020.
He was also a Partner at Wise Equity SGR SpA from 2004 to 2016.
Additionally, he held positions as a Director at Finanziaria Canova SpA and OphthalmoPharma AG.
Aktive Positionen von Roberto Saviane
| Unternehmen | Position | Beginn |
|---|---|---|
Pitagora SpA
 Pitagora SpA Finance/Rental/LeasingFinance Pitagora SpA provides financing and consumer credit services. It offers business and salary loans. The company was founded by Massimo Sanson in 1995 and is headquartered in Turin, Italy. | Direktor/Vorstandsmitglied | 19.03.2010 |
Ehemalige bekannte Positionen von Roberto Saviane
| Unternehmen | Position | Ende |
|---|---|---|
Dea Capital Alternative Funds SGR SpA
 Dea Capital Alternative Funds SGR SpA Investment ManagersFinance DeA Capital Alternative Funds SGR SpA (Dea Capital Alternative Funds) is a private equity subsidiary of DeA Capital SpA (Private Equity) founded in 2000. The firm is headquartered in Milan, Italy. | Vorsitzender | 20.04.2020 |
OphthalmoPharma AG
 OphthalmoPharma AG Medical SpecialtiesHealth Technology OphthalmoPharma AG develops ophthalmology treatments. Its product pipeline addresses major unmet medical needs including dry eye syndrome, glaucoma, and age-related macular degeneration. The company's product include EyeBar, a nutraceutical for the prevention of dry age-related macular degeneration and the preloaded injector for delivery of intraocular lens in cataract and corrective lens replacement surgery. OphthalmoPharma was founded by Sebastien Putallaz and Gamil G. de Chadarevian in 2003 and is headquartered in Sarnen, Switzerland. | Direktor/Vorstandsmitglied | - |
Wise Equity SGR SpA
 Wise Equity SGR SpA Investment ManagersFinance Wise Equity SGR SpA (Wise equity) is a private equity firm founded in 2000 by Paolo Gambarini and Michele Semenzato. The firm is headquartered in Milan, Italy. | Direktor/Vorstandsmitglied | - |
Finanziaria Canova SpA
 Finanziaria Canova SpA Financial ConglomeratesFinance Finanziaria Canova SpA operates as a holding company. It provides administrative, business planning and consulting services. The company was founded in September 2001 and is headquartered in Milan, Italy. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Finanziaria Canova SpA
Finanziaria Canova SpA Financial ConglomeratesFinance Finanziaria Canova SpA operates as a holding company. It provides administrative, business planning and consulting services. The company was founded in September 2001 and is headquartered in Milan, Italy. | Finance |
Wise Equity SGR SpA
Wise Equity SGR SpA Investment ManagersFinance Wise Equity SGR SpA (Wise equity) is a private equity firm founded in 2000 by Paolo Gambarini and Michele Semenzato. The firm is headquartered in Milan, Italy. | Finance |
Dea Capital Alternative Funds SGR SpA
Dea Capital Alternative Funds SGR SpA Investment ManagersFinance DeA Capital Alternative Funds SGR SpA (Dea Capital Alternative Funds) is a private equity subsidiary of DeA Capital SpA (Private Equity) founded in 2000. The firm is headquartered in Milan, Italy. | Finance |
Pitagora SpA
Pitagora SpA Finance/Rental/LeasingFinance Pitagora SpA provides financing and consumer credit services. It offers business and salary loans. The company was founded by Massimo Sanson in 1995 and is headquartered in Turin, Italy. | Finance |
OphthalmoPharma AG
OphthalmoPharma AG Medical SpecialtiesHealth Technology OphthalmoPharma AG develops ophthalmology treatments. Its product pipeline addresses major unmet medical needs including dry eye syndrome, glaucoma, and age-related macular degeneration. The company's product include EyeBar, a nutraceutical for the prevention of dry age-related macular degeneration and the preloaded injector for delivery of intraocular lens in cataract and corrective lens replacement surgery. OphthalmoPharma was founded by Sebastien Putallaz and Gamil G. de Chadarevian in 2003 and is headquartered in Sarnen, Switzerland. | Health Technology |